- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Adnan Mjalli, TransTech Pharma
S
Adnan Mjalli
Co-founder, President, CEO, TransTech Pharma
BORN: On the West Bank, Jerusalem, to farmers
BIGGEST ACCOMPLISHMENT: Key discoveries in Alzheimer's and diabetes
People can manufacture cars, computers, everything, faster and cheaper," says Adnan Mjalli. "Everything around us has become more portable and available, except for medicine. It's embarrassing how Big Pharma has become an old, rusty environment for drug discovery."
Adnan Mjalli
The argument would be easier to dismiss if he wasn't such a prolific scientist. But with more than 620 patents under his belt and a slew of INDs, Mjalli underscores his point with the success of the company he founded, TransTech Pharma.
Mjalli says the engine of the success is his proprietary translational technology platform, which was used to discover all of the company's portfolio drugs. The platform's effectiveness has led the company to strike deals with a major pharma for each of the last seven years.
Mjalli received much of his training as a scientist while working at Merck, but marries those skills with a natural bent for business. "I've always had good judgment on which scientific area would lead to a breakthrough," he says. "We're seeing more scientists coming out of the lab to understand the business, like the scientists who head Vertex and Cephalon. They do a much better job than a pure CEO of connecting the business to the work that goes on every day."
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
